InvestorsHub Logo
Followers 16
Posts 395
Boards Moderated 0
Alias Born 12/05/2012

Re: None

Monday, 05/05/2014 11:38:43 AM

Monday, May 05, 2014 11:38:43 AM

Post# of 130503
Continuing development of the MANF/PD program. A few hidden info bits about CED findings and results....

US Patent for PD Treatment of PD
WO/2014/066686 - BRAIN TARGETS FOR NEUROTROPHIC FACTORS TO TREAT NEURODEGENERATIVE DISEASE 01.05.2014 A61K 38/18
PCT/US2013/066688 AMARANTUS BIOSCIENCE HOLDINGS, INC. COMMISSIONG, John, W.
http://patentscope.wipo.int/search/en/detail.jsf?docId=WO2014066686&recNum=1&maxRec=10&office=&prevFilter=&sortOption=Pub+Date+Desc&queryString=FP%3A%28commissiong%29&tab=PCTDescription


International application for MANF for PD status as of 5/5/2014
http://patentscope.wipo.int/search/iasr?ia=US2013066688&PAGE=HTML&ACCESS=screen&TOK=YUbO3Yw_Xe7rLOU1IwwOS8siUHQ